OMERS Administration Corp’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.48M Buy
44,504
+21,950
+97% +$1.72M 0.03% 215
2025
Q1
$1.63M Sell
22,554
-110,846
-83% -$8.03M 0.01% 445
2024
Q4
$9.88M Buy
133,400
+3,481
+3% +$258K 0.09% 106
2024
Q3
$8.57M Sell
129,919
-24,000
-16% -$1.58M 0.08% 119
2024
Q2
$14.2M Buy
153,919
+23,773
+18% +$2.2M 0.14% 74
2024
Q1
$12.4M Sell
130,146
-4,140
-3% -$396K 0.14% 61
2023
Q4
$10.2M Buy
134,286
+31,094
+30% +$2.37M 0.13% 69
2023
Q3
$7.15M Buy
103,192
+49,478
+92% +$3.43M 0.11% 70
2023
Q2
$5.07M Hold
53,714
0.08% 77
2023
Q1
$4.44M Sell
53,714
-8,821
-14% -$730K 0.07% 80
2022
Q4
$4.67M Buy
62,535
+27,169
+77% +$2.03M 0.07% 73
2022
Q3
$2.92M Hold
35,366
0.05% 84
2022
Q2
$3.36M Buy
+35,366
New +$3.36M 0.05% 86
2021
Q4
Sell
-51,859
Closed -$5.87M 412
2021
Q3
$5.87M Buy
+51,859
New +$5.87M 0.09% 65
2021
Q2
Sell
-45,098
Closed -$3.77M 41
2021
Q1
$3.77M Buy
45,098
+4,052
+10% +$339K 0.06% 69
2020
Q4
$3.75M Buy
+41,046
New +$3.75M 0.07% 84
2020
Q1
Sell
-128,400
Closed -$9.99M 255
2019
Q4
$9.99M Sell
128,400
-4,800
-4% -$373K 0.12% 99
2019
Q3
$9.76M Buy
133,200
+10,200
+8% +$748K 0.1% 105
2019
Q2
$7.68M Buy
123,000
+7,500
+6% +$468K 0.08% 129
2019
Q1
$7.63M Buy
+115,500
New +$7.63M 0.09% 72
2016
Q4
Sell
-163,500
Closed -$6.57M 397
2016
Q3
$6.57M Buy
163,500
+57,900
+55% +$2.33M 0.12% 118
2016
Q2
$3.51M Sell
105,600
-21,300
-17% -$708K 0.07% 170
2016
Q1
$3.73M Sell
126,900
-47,100
-27% -$1.38M 0.08% 154
2015
Q4
$4.58M Sell
174,000
-65,400
-27% -$1.72M 0.12% 140
2015
Q3
$5.67M Buy
239,400
+4,200
+2% +$99.5K 0.17% 120
2015
Q2
$5.58M Buy
+235,200
New +$5.58M 0.22% 112